September 11, 2013
The Pharmaceuticals and Medical Devices Agency (PMDA) intends to require drug makers to submit clinical trial data for their new drug applications (NDAs) in electronic formats, beginning in FY2016—a move that would allow the authority to efficiently store and analyze...read more